› 5ca1

X-ray diffraction
2.4Å resolution

Crystal structure of T2R-TTL-Nocodazole complex

Released:
DOI: 10.2210/pdb5ca1/pdb
Model geometry
Fit model/data
PDB entry 5ca1 coloured by chain, front view.
PDB entry 5ca1 coloured by chain, side view.
PDB entry 5ca1 coloured by chain, top view.
Source organisms:
Primary publication:
Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
Wang Y, Zhang H, Gigant B, Yu Y, Wu Y, Chen X, Lai Q, Yang Z, Chen Q, Yang J
FEBS J 283 102-11 (2016)
PMID: 26462166

Function and Biology Details

Biochemical function:
Biological process:
Cellular component:
Sequence domains:

Structure analysis Details

Assembly composition:
hetero hexamer (preferred)
PDBe Complex ID:
PDB-CPX-236643 (preferred)
Entry contents:
4 distinct polypeptide molecules
Macromolecules (4 distinct):
Tubulin alpha chain Chains: A, C
Molecule details ›
Chains: A, C
Length: 450 amino acids
Theoretical weight: 50.04 KDa
Source organism: Sus barbatus
UniProt:
  • Canonical: A0A0R4I993 (Residues: 1-450; Coverage: 100%)
Sequence domains:
Structure domains:
Tubulin beta-2 chain Chains: B, D
Molecule details ›
Chains: B, D
Length: 445 amino acids
Theoretical weight: 50 KDa
Source organism: Gallus gallus
Expression system: Escherichia coli
UniProt:
  • Canonical: P32882 (Residues: 1-445; Coverage: 100%)
Sequence domains:
Structure domains:
Stathmin-4 Chain: E
Uncharacterized protein Chain: F

Ligands and Environments

8 bound ligands:
Ligand GTP 2 x GTP
Ligand MG 3 x MG
Ligand CA 2 x CA
Ligand GOL 1 x GOL
Ligand GDP 2 x GDP
Ligand MES 2 x MES
Ligand NZO 2 x NZO
Ligand ACP 1 x ACP
No modified residues

Experiments and Validation Details

wwPDB Validation report is not available for this entry.
X-ray source: SSRF BEAMLINE BL19U1
Spacegroup: P212121
Unit cell:
a: 105.44Å b: 158.362Å c: 180.692Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.193 0.192 0.225
Expression system: Escherichia coli

Quick links

Citations

9 review citations

Non-kinase targets of protein kinase inhibitors.
Munoz L. (2017)
8 more

18 mentions without citation

Review of Characteristics and Analytical Methods for Determination of Thiabendazole.
Budetić et al. (2023)
17 more

PDB-REDO

The sliders below show the change in model quality between original PDB entry and the PDB-REDO entry

Model Geometry
 
 
Data not available
DNA/RNA Geometry
 
 
Data not available
Fit model/data
 
 
Data not available
PDB-REDO